Literature DB >> 8694704

Corticosteroid therapy of eye disease. Fifty years later.

M Raizman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694704     DOI: 10.1001/archopht.1996.01100140208016

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  19 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Pharmacologic uncoupling of angiogenesis and inflammation during initiation of pathological corneal neovascularization.

Authors:  Jeremy M Sivak; Allison C Ostriker; Amber Woolfenden; John Demirs; Rosemarie Cepeda; Debby Long; Karen Anderson; Bruce Jaffee
Journal:  J Biol Chem       Date:  2011-11-09       Impact factor: 5.157

3.  Regulatory effect of dexamethasone on aquaporin-1 expression in cultured bovine trabecular meshwork cells.

Authors:  Xinchun Xiong; Juan Miao; Zulian Xi; Haijiang Zhang; Bo Han; Yizhen Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 4.  Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems.

Authors:  Nicholas Bodor; Peter Buchwald
Journal:  AAPS J       Date:  2005-12-07       Impact factor: 4.009

5.  Local treatment with alpha-melanocyte stimulating hormone reduces corneal allorejection.

Authors:  Pedram Hamrah; Zdenka Haskova; Andrew W Taylor; Qiang Zhang; Bruce R Ksander; M Reza Dana
Journal:  Transplantation       Date:  2009-07-27       Impact factor: 4.939

6.  Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis).

Authors:  Reza Dana
Journal:  Trans Am Ophthalmol Soc       Date:  2007

7.  Antimicrobial management of presumed microbial keratitis: guidelines for treatment of central and peripheral ulcers.

Authors:  H G Bennett; J Hay; C M Kirkness; D V Seal; P Devonshire
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

Review 8.  Topical ocular delivery of NSAIDs.

Authors:  Munish Ahuja; Avinash S Dhake; Surendra K Sharma; Dipak K Majumdar
Journal:  AAPS J       Date:  2008-04-25       Impact factor: 4.009

9.  Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis.

Authors:  Shintaro Nakao; Yasuaki Hata; Muneki Miura; Kousuke Noda; Yusuke N Kimura; Shuhei Kawahara; Takeshi Kita; Toshio Hisatomi; Toru Nakazawa; Yiping Jin; M Reza Dana; Michihiko Kuwano; Mayumi Ono; Tatsuro Ishibashi; Ali Hafezi-Moghadam
Journal:  Am J Pathol       Date:  2007-08-09       Impact factor: 4.307

10.  Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist.

Authors:  Ming-Ling Tsai; Chi-Ting Horng; Show-Li Chen; Xiao Xiao; Chih-Hung Wang; Yeou-Ping Tsao
Journal:  Mol Vis       Date:  2009-08-08       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.